FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Fitbit Emergency Use Ventilator

FDA grants Fitbit an emergency use authorization for its emergency ventilator, Fitbit Flow, for use during the Covid-19 public health emergency.

Human Drugs

FDA Reminder on Proper Transport Media

FDA reminds laboratories to use transport media that are compatible with Covid-19 testing platforms and the processes used in their laboratory to proc...

Human Drugs

FDA Regulatory Flexibility for Antimicrobials Analyzed

Harvard Medical School researchers say that in the last 30 years antimicrobial products have frequently qualified for FDA expedited clinical testing a...

Biologics

Favored Vaccine Candidates Got Public Funding: Report

Public Citizen calls for publication of federal contracts with five leading candidates to manufacture a Covid-19 vaccine, all of whom have received si...

Human Drugs

AuroLife Pharma Form 483 Issued After Inspection

India-based Aurobindo Pharma says that a recent FDA inspection at its Dayton, NH, AuroLife Pharma unit resulted in a Form 483 citing nine GMP observat...

Top FDAer Quits Operation Warp Speed

A lengthy Politico article sees the return of CBER director Peter Marks to full-time FDA duty from Operation Warp Speed as one example of political in...

Compliance Guide for Some Combination Products

FDA issues a compliance guide for inspections of CDER-led and CDRH-led combination products.

Human Drugs

PharmaEssentia BLA for Polycythemia Vera Therapy

FDA accepts for review a PharmaEssentia BLA for ropeginterferon alfa-2b (P1101), a novel pegylated interferon intended for treating rare blood cancer ...

Human Drugs

Mercks Recarbrio OKd for Hospital Pneumonia

FDA approves a Merck NDA for Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventil...

Human Drugs

Covid IRB Expanded Access Guidance

FDA issues an immediately-in-effect guidance on IRB procedures and factors to consider for individual patient expanded access requests during the publ...